Skip to main content
Clinical Trials/NCT02554097
NCT02554097UnknownNot Applicable

Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System

Beijing Friendship Hospital1 site in 1 country2,700 target enrollmentStarted: August 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
2,700
Locations
1
Primary Endpoint
Rate of Adverse outcomes

Study Overview

Brief Summary

Patients with gallstone and confirmed common bile duct stones are registered in this study. The three managements for common bile duct stones are endoscopic sphincterotomy (EST), laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative investigations, operative method, operative time, conversion to open procedure, intraoperative and postoperative complications, and the presence of retained and recurrent stones. All patients were followed up for 3 years by telephone interview ang outpatient visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom appeared during the follow-up period. If there were unusual findings, magnetic resonance cholangiopancreatography(MRCP) was carried out.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with age between 18 - 80 years.
  • Patients diagnosed with gallstones.
  • Patients diagnosed with common bile duct stone by one of the three exam (MRI、MRCP and CT).
  • Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration.
  • Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).

Exclusion Criteria

  • Combined with Mirizzi syndrome and intrahepatic bile duct stones
  • Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD)
  • History of upper abdominal surgery.
  • Serious heart,brain,lung, metabolic diseases history.
  • Pregnant women
  • Unwillingness or inability to consent for the study.

Outcomes

Primary Outcomes

Rate of Adverse outcomes

Time Frame: 3 years

The patients with complication / the total patients

Secondary Outcomes

  • Hospital stay(3 years)
  • Stricture of the bile duct rate rate(3 years)
  • Operation time(3 years)
  • Bile leakage rate(30 days)
  • Mortality(3 years)
  • Perforation Rate(30 days)
  • Acute cholangitis rate(30 days)
  • Hemorrhage Rate(3 years)
  • Acute pancreatitis Rate(30 days)
  • Incremental cost-effectiveness ratio(3 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhongtao Zhang

Doctor

Beijing Friendship Hospital

Study Sites (1)

Loading locations...

Similar Trials

Chinese Registry Study on Treatment of... | Clinical Trial